Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. Knight DA, Ngiow SF, Li M, Parmenter T, et al. J Clin Invest 2023;133:e177489.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Knight DA, Ngiow SF, Li M, Parmenter T, et al. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. J Clin Invest 2023;133:e177489.
PMID: 38099495